Monitoring direct thrombin inhibitors with routine and dedicated coagulation assays : which assay is helpful?

J. Curvers, D.H. Kerkhof, van de, A.K. Stroobants, E.J. Dool, van den, V. Scharnhorst

Research output: Contribution to journalArticleAcademicpeer-review

52 Citations (Scopus)

Abstract

The use of direct thrombin inhibitors (DTIs) for prophylactic or therapeutic anticoagulation is increasing because of the predictable bioavailability and short half-life of these DTIs. However, in certain situations, indication of the concentration is warranted. We investigated the effects of 3 DTIs (lepirudin, argatroban, and bivalirudin) in 6 pooled plasma specimens on routine coagulation assays (activated partial thromboplastin time [aPTT], prothrombin time [PT], and thrombin time [TT]) and dedicated DTI assays (Hemoclot, HemosIL, the ecarin clotting time, and a chromogenic ecarin clotting time) on 2 coagulation analyzers. We found routine tests to be nondiscriminative between concentrations of different DTIs in the aPTT. Moreover, for PT and TT, the responses for different DTIs differed. This was similar for ecarin clotting assays. The Hemoclot and HemosIL assays showed identical linear increases for all 3 DTIs. We conclude that dedicated calibrated assays based on a diluted TT (Hemoclot and HemosIL) appear to be the most suitable for monitoring purposes.
Original languageEnglish
Article number4
Pages (from-to)551-558
JournalAmerican Journal of Clinical Pathology
Volume138
DOIs
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'Monitoring direct thrombin inhibitors with routine and dedicated coagulation assays : which assay is helpful?'. Together they form a unique fingerprint.

Cite this